Telomere shortening correlates with increasing aneuploidy of chromosome 8 in human hepatocellular carcinoma

被引:53
作者
Plentz, RR
Schlegelberger, B
Flemming, P
Gebel, M
Kreipe, H
Manns, MP
Rudolph, KL
Wilkens, L
机构
[1] Hannover Med Sch, Dept Gastroenterol Hepatol & Endocrinol, D-30625 Hannover, Germany
[2] Hannover Med Sch, Inst Cell & Mol Pathol, D-30625 Hannover, Germany
[3] Hannover Med Sch, Dept Pathol, D-30625 Hannover, Germany
关键词
D O I
10.1002/hep.20847
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Chromosomal instability (CIN) leads to an increase in aneuploidy and chromosomal aberrations in human hepatocellular carcinoma (HCC). Telomere shortening appears as one mechanism fostering the development of CIN. Whether telomere shortening correlates to specific genetic changes that characterize a certain type of cancer has yet to be established. In our recent study, we combined on a cellular level the analysis of hepatocellular telomere fluorescent intensity (TFI) and copy number of chromosome 8-one of the hallmark chromosomal alterations in hepatocellular carcinoma (HCC). We investigated 15 cytological fine-needle biopsies of aneuploid HCC and 5 touch prints of cadaver livers without cancer. Hepatocyte-specific TFI and the measurement of centromere-specific probe for chromosome 8 were both performed by quantitative fluorescence in situ hybridization (qFISH) or FISH. Combined analysis of both methods (coFISH) allowed measurement of telomere length and chromosome 8 copy number on a single cell level. We observed that telomere shortening correlates significantly with increasing copy number of chromosome 8 in HCC on the cellular level. Above the level of 5 copies of chromosome 8 per nucleus, no further shortening of telomeres was found, indicating that telomeres had reached a critically short length at this stage of aneuploidy. In conclusion, our study gives direct evidence that telomere shortening is linked to a specific genetic alteration characteristic for human HCC.
引用
收藏
页码:522 / 526
页数:5
相关论文
共 30 条
[1]   Telomere shortening and tumor formation by mouse cells lacking telomerase RNA [J].
Blasco, MA ;
Lee, HW ;
Hande, MP ;
Samper, E ;
Lansdorp, PM ;
DePinho, RA ;
Greider, CW .
CELL, 1997, 91 (01) :25-34
[2]   Vitamin E down-modulates iNOS and NADPH oxidase in c-Myc/TGF-α transgenic mouse model of liver cancer [J].
Calvisi, DF ;
Ladu, S ;
Hironaka, K ;
Factor, VM ;
Thorgeirsson, SS .
JOURNAL OF HEPATOLOGY, 2004, 41 (05) :815-822
[3]  
Djojosubroto MW, 2003, MOL CELLS, V15, P164
[4]   Hepatocellular carcinoma - An epidemiologic view [J].
El-Serag, HB .
JOURNAL OF CLINICAL GASTROENTEROLOGY, 2002, 35 (05) :S72-S78
[5]  
EMI M, 1992, CANCER RES, V52, P5368
[6]   Vitamin E reduces chromosomal damage and inhibits hepatic tumor formation in a transgenic mouse model [J].
Factor, VM ;
Laskowska, D ;
Jensen, MR ;
Woitach, JT ;
Popescu, NC ;
Thorgeirsson, SS .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (05) :2196-2201
[7]   GENETIC CHANGES AND HISTOPATHOLOGICAL GRADES IN HUMAN HEPATOCELLULAR CARCINOMAS [J].
KONISHI, M ;
KIKUCHIYANOSHITA, R ;
TANAKA, K ;
SATO, C ;
TSURUTA, K ;
MAEDA, Y ;
KOIKE, M ;
TANAKA, S ;
NAKAMURA, Y ;
HATTORI, N ;
MIYAKI, M .
JAPANESE JOURNAL OF CANCER RESEARCH, 1993, 84 (08) :893-899
[8]   Genetic aberrations detected by comparative genomic hybridization in hepatocellular carcinomas: Their relationship to clinicopathological features [J].
Kusano, N ;
Shiraishi, K ;
Kubo, K ;
Oga, A ;
Okita, K ;
Sasaki, K .
HEPATOLOGY, 1999, 29 (06) :1858-1862
[9]   Genetic alterations associated with hepatocellular carcinomas define distinct pathways of hepatocarcinogenesis [J].
Laurent-Puig, P ;
Legoix, P ;
Bluteau, O ;
Belghiti, J ;
Franco, D ;
Binot, F ;
Monges, G ;
Thomas, G ;
Bioulac-Sage, P ;
Zucman-Rossi, J .
GASTROENTEROLOGY, 2001, 120 (07) :1763-1773
[10]   Genetic instabilities in human cancers [J].
Lengauer, C ;
Kinzler, KW ;
Vogelstein, B .
NATURE, 1998, 396 (6712) :643-649